Related Experiment Video
Updated: May 14, 2026
04:04
Lateral Molar Approach-Driven Transoral Endoscopic Procedure for Benign Infratemporal Fossa Tumor Resection
Published on: August 15, 2025
Extramedullary plasmacytoma of maxillary sinus
Banu Atalay Erdogan1, Ozgur Sekercan, Nevra Dursun
1Otorhinolaryngology Department, Kartal Dr. Lutfi Kirdar Education and Research Hospital, Istanbul, Turkey. banuatalay81@gmail.com
The Journal of Craniofacial Surgery
|January 26, 2013
Summary
Solitary extramedullary plasmacytomas are rare head and neck tumors. Diagnosis requires excluding systemic disease, with radiotherapy as the primary treatment for maxillary sinus plasmacytoma.
Area of Science:
- Oncology
- Head and Neck Surgery
- Radiotherapy
Background:
- Solitary extramedullary plasmacytomas (SEPs) are uncommon neoplasms.
- These tumors frequently occur in the head and neck region.
- Diagnosis necessitates excluding systemic multiple myeloma through comprehensive investigations.
Observation:
- A case report of a 62-year-old male patient is presented.
- The patient presented with an extramedullary plasmacytoma originating in the left maxillary sinus.
- The patient was referred for chemoradiotherapy.
Findings:
- Extramedullary plasmacytoma in the maxillary sinus is a rare presentation.
- Exclusion of systemic disease is critical for accurate diagnosis.
- Radiotherapy is the established primary treatment modality.
Implications:
- This case highlights the importance of considering SEPs in the differential diagnosis of head and neck masses.
- Accurate diagnosis and staging are crucial for appropriate treatment planning.
- Chemoradiotherapy may be a viable treatment option for localized maxillary sinus plasmacytomas.
